A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.

In a new study published in Science Translational Medicine, investigators have shown that HIV can acquire mutations that cause resistance to lenacapavir—but at a huge cost to the virus itself.

He said Fiji recorded 2,003 new HIV diagnoses in 2025, compared with 1,583 in 2024, while the national diagnosis rate has surged significantly.

South Africa’s National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic ...

You are enjoying a warm summer evening outdoors, and you feel the familiar, itchy pinch of a mosquito bite.

South Africa’s National Aids Council has launched a renewed effort to secure licences to make generic versions of lenacapavir in the country. This is how it is going about it.

Charities warn estates of victims who died before the scheme began are losing hundreds of thousands in financial loss payments ...

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...

South Africa's National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that could end Aids by 2043 in the country.

Herpes simplex virus partially liquifies the tightly packed, gel-like interior of human cell nuclei to copy itself faster, a new study shows. The research centers on how the nucleus of each human cell ...